Hortolândia, Brazil

Heny Zaniboni

This inventor holds 2 USPTO granted patents. Top assignees: Nature's Plus Farmacêutica Ltda., Sigma Pharma Ltda.. Active years: 2011-2012.


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Hortolandia, BR (2011)
  • Hortolândia, BR (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Heny Zaniboni: Innovator in Pharmaceutical Compositions

Introduction

Heny Zaniboni is a notable inventor based in Hortolândia, Brazil. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for sublingual administration. With a total of 2 patents, her work focuses on enhancing the efficacy of pharmaceutical compounds.

Latest Patents

Heny's latest patents include a pharmaceutical composition based on an agonist of benzodiazepine. This invention describes the use of pharmaceutical compounds for sublingual administration, incorporating active ingredients such as diazepam, lorazepam, and others, mixed with excipients like lactose, sorbitol, and cellulose. Another significant patent is for sublingual formulations of ketorolac or its salts. This invention aims to accelerate the pharmacological response to ketorolac without the need for injectable methods, utilizing a ternary mixture of lactose, sorbitol, and cellulose as essential excipients.

Career Highlights

Throughout her career, Heny has worked with reputable companies such as Sigma Pharma Ltda. and Nature's Plus Farmacêutica Ltda. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Heny has collaborated with notable professionals in her field, including Guido Vandoni and Carlo Oliani. These partnerships have further enriched her work and expanded her impact in the pharmaceutical industry.

Conclusion

Heny Zaniboni's contributions to pharmaceutical compositions demonstrate her commitment to innovation and improving patient care. Her patents reflect a deep understanding of the complexities of drug formulation and administration.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…